Rethinking Clinical Trial Operations with AI and Remote Monitoring - with Scott Bradley of Novartis
Release Date: 10/28/2025
Rethinking Clinical Trials with Faster AI-Driven Decision Making - with Shefali Kakar of Novartis
The AI in Business Podcast
Shefali Kakar, Global Head of PK Sciences and Oncology at Novartis, returns to the AI in Business podcast to discuss how AI is reshaping the earliest and most critical phases of drug development—where strategic investment decisions are made long before a clinical trial begins. Together with Emerj Editorial Director Matthew DeMello, Shefali explores how advanced modeling, in silico design, and patient data are creating a clearer picture of risk and return across R&D portfolios. She explains how pharmaceutical organizations are leveraging multi-factorial models to simulate safety,...
info_outline
Human-Centered Innovation Driving Better Nurse Experiences - with Umesh Rustogi of Microsoft
The AI in Business Podcast
Today’s guest is Umesh Rustogi, General Manager of Dragon for Nursing, Microsoft Health & Life Sciences. Umesh joins Emerj Editorial Director Matthew DeMello to explore how nursing workflows are straining under documentation burden, and how ambient AI is being built — not repurposed — to fit the realities of frontline care. The conversation also examines practical workflow changes already emerging in the field, as well as early ROI signals to watch for. Want to share your AI adoption story with executive peers? Click for more information and to be a potential future guest on the...
info_outline
The Biggest Cybersecurity Challenges Facing Regulated and Mid-Market Sectors - with Cody Barrow of EclecticIQ
The AI in Business Podcast
Today’s guest is Cody Barrow, CEO at EclecticIQ. EclecticIQ is a global cybersecurity leader specializing in threat intelligence technology. Cody joins Emerj Editorial Director Matthew DeMello to discuss how AI-driven analytics and automation are revolutionizing threat detection and response in enterprise cybersecurity. Barrow also highlights practical improvements in workflow automation, early threat identification, and measurable ROI through reduced breach risks and operational efficiency. This episode is sponsored by EclecticIQ. Learn how brands work with Emerj and other Emerj Media...
info_outline
Overcoming Cloud Complexity in Mid Market Operations - with Dirk Michiels of Savaco
The AI in Business Podcast
Today’s guest is Dirk Michiels, CEO of Savaco. Savaco is a Belgium-based managed service provider specializing in hybrid cloud solutions, cybersecurity, and enterprise software deployment. Michiels joins Emerj Editorial Director Matthew DeMello to discuss the transformative role of hybrid cloud architectures in enterprise data and AI strategies. He also highlights how seamless integration, enhanced security protocols, and optimized deployment workflows lead to faster innovation and measurable ROI for modern organizations. This episode is sponsored by Xurrent. Learn how brands work with Emerj...
info_outline
From Hiring to Growth and the Future of Workforce Strategy - with Meghna Punhani of Eightfold AI
The AI in Business Podcast
Today’s guest is Meghna Punhani, Chief People Officer at Eightfold AI. Eightfold AI provides an AI-powered platform for talent management, helping organizations optimize hiring, internal mobility, and workforce development. Meghna joins Emerj Editorial Director Matthew DeMello to discuss how HR leaders can adopt AI responsibly to enhance workforce capabilities and drive strategic impact. She also shares practical insights on reengineering HR workflows, leveraging AI for candidate screening and internal mobility, and building human-centered ethical guardrails for AI implementation. This...
info_outline
"Waking Up" Data in Clinical Workflows with AI - with Mathew Paruthickal of Sanofi
The AI in Business Podcast
Today’s guest is Mathew Paruthickal, Global Head of Data Architecture, Utilization, and AI Engineering at Sanofi. Founded in 1973, Sanofi is a French multinational pharmaceutical and healthcare company. Sanofi works in the research, development, and manufacturing of pharmaceuticals and vaccines. Mathew joins Emerj Editorial Director Matthew DeMello to explore how life sciences organisations can move from isolated digital tools to orchestrated, interoperable systems and how engineering teams can bake in traceability, auditability, and human-in-the-loop governance from day one. Want to share...
info_outline
Copyright Risk in Financial Services and the Rise of Responsible AI – with Lauren Tulloch of CCC
The AI in Business Podcast
Today’s guest is Lauren Tulloch, Vice President and Managing Director at CCC (Copyright Clearance Center). CCC provides collective copyright licensing services for corporate and academic users of copyrighted materials, and, as one can imagine, the advent of AI has exposed a large number of businesses to copyright risks they’ve never considered before. Today, Lauren joins us to discuss where copyright exposure arises in financial services, from the growth of AI development to more commonplace employee use. With well over a decade at the company, Lauren dives into the urgent need for...
info_outline
Why False Positives Are Costing Banks More Than Fraud - with Suvaleena Paul of Bank of America
The AI in Business Podcast
Today’s guest is Suvaleena Paul, Assistant Vice President and Senior Analyst in Fraud, Innovation, and Analysis at Bank of America. Suvaleena joins Emerj Editorial Director Matthew DeMello to discuss the integration of AI-driven technologies into fraud prevention workflows. She also shares practical insights on improving threat identification speed, fostering cross-team collaboration, and continuously refining AI models to maximize ROI and maintain regulatory compliance. Want to share your AI adoption story with executive peers? Click for more information and to be a potential future guest...
info_outline
Using Artificial Intelligence to Unlock Hidden Insights in Genomic Research - with Dr. Mark Kiel of Genomenon
The AI in Business Podcast
Today’s guest is Dr. Mark Kiel, Chief Science Officer and Founder at Genomenon. Genomenon is a genomics intelligence company that unlocks real-world evidence from biomedical literature to help pharmaceutical and clinical diagnostics companies inform precision medicine, accelerate patient diagnosis, and guide trial design and label expansion. Mark joins Emerj Editorial Director Matthew DeMello to explore how AI can streamline the extraction, organization, and interpretation of genomic and clinical data, enabling faster, more accurate decision-making in pharmaceutical R&D. He also shares...
info_outline
Driving the Systemic Change for AI – with Deborah Golden of Deloitte
The AI in Business Podcast
The gap between a promising AI pilot and enterprise-wide, scalable impact remains a critical divide where momentum and resources often stall. Today’s guest is Deborah Golden, U.S. Chief Innovation Officer at Deloitte who returns to the show to join Emerj CEO Daniel Faggella to tackle the costly reality of stalled AI initiatives. This conversation moves beyond traditional theory, offering a new strategic lens for driving the systemic and cultural change required to scale AI responsibly. Deborah shares how leaders can overcome deep-seated organizational inertia that typically hinders...
info_outlineToday’s guest is Scott Bradley, VP of AI and Innovation at Novartis. As the eighth largest pharmaceutical company in the world by revenue, Novartis’ medicines reach millions of people worldwide. Their focus on the discovery and development of novel, breakthrough treatments sees them reimagining not just the delivery of said treatments, but the practice of medicine at large. Scott joins Emerj Editorial Director Matthew DeMello to examine how artificial intelligence is transforming trial design, operations, and patient engagement — while also reshaping industry trust and accountability. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the ‘AI in Business’ podcast!